IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2009
(Investigative Ophthalmology and Visual Science. )
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.08-2536

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.08-2536v1
50/1/263    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugita, S.
Right arrow Articles by Yamagami, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugita, S.
Right arrow Articles by Yamagami, S.

Article

Human Corneal Endothelial Cells Expressing Programmed Death-Ligand 1 (PD-L1) Suppress PD-1+ T Helper 1 Cells by a Contact-Dependent Mechanism

Sunao Sugita 1*, Yoshihiko Usui 2, Shintaro Horie 3, Yuri Futagami 3, Yukiko Yamada 3, Juan Ma 2, Takeshi Kezuka 2, Hirofumi Hamada 4, Tomohiko Usui 5, Manabu Mochizuki 3, and Satoru Yamagami 6

1 Department of Ophthalmology, Tokyo Medical & Dental Univ., Yushima1-5-45, Bunko-ku, Tokyo, 113-8519, Japan
2 Ophthalmology, Tokyo Medical University, Tokyo, Japan
3 Ophthalmology, Tokyo Medical and Dental University, Tokyo, Japan
4 Molecular Medicine, Sapporo Medical University, Sapporo, Japan
5 Ophthalmology, University of Tokyo, Tokyo, Japan
6 Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan

* To whom correspondence should be addressed. E-mail: sunaoph{at}tmd.ac.jp.


   Abstract

Purpose. To determine whether a human corneal endothelial (CE) cells could regulate the activation of bystander T cells in vitro. Methods. Human CE (HCE) cell lines were established from primary HCE cells. Targetactivated T cells were used allogeneic T cells and Jurkat T cell lines. As an additional target, T cell clones from uveitis patients were established from aqueous humor via a limiting dilution. Tcell activation was assessed for proliferation by [3H]-thymidine incorporation, CFSEincorporation, or IFN{gamma} production. Expression of co-stimulatory molecules on IFN{gamma}-treated CE & non-treated cells were evaluated by flow cytometry, RT-PCR, or immunohistochemistry. Expression of co-stimulatory receptors on target T cells was evaluated by flow cytometry. Blocking antibodies was used to abolish the HCE-inhibitory function. Results. HCE cells suppressed both in vitro proliferation and IFN{gamma} production by CD4+ T cells via a cell contact-dependent mechanism. HCE constitutively expressed co stimulatory molecules programmed death-ligand 1 (PD-L1) and PD-L2, and their expression was enhanced by IFN{gamma}. HCE efficiently inhibited the proliferation of Th1 cells that overexpressed PD-1 among various activated T cell lines and clones established from patients with uveitis or corneal endotheliitis. A neutralizing mAb for PD-L1, but not PD-L2, blocked the suppressive effect of HCE on Th1 cells. Conclusions. HCE can impair the effector functions and activation of Th1 infiltrating CD4+ T cells via the PD-1/PD-L1 interaction. Our data support the hypothesis that corneal endothelium may contribute to maintenance of the privileged immune status of the anterior chamber of the eye by inducing peripheral immune tolerance.

Key Words: suppression, corneal endothelial cells, immune privilege, immunoregulation, uveitis




This article has been cited by other articles:


Home page
IOVSHome page
T. Hayashi, S. Yamagami, K. Tanaka, S. Yokoo, T. Usui, S. Amano, and N. Mizuki
Immunologic Mechanisms of Corneal Allografts Reconstituted from Cultured Allogeneic Endothelial Cells in an Immune-Privileged Site
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3151 - 3158.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Association for Research in Vision and Ophthalmology